載入...
HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies
BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...
Na minha lista:
| 發表在: | J Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596543/ https://ncbi.nlm.nih.gov/pubmed/33144857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8860174 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|